Peroxisome proliferator-activated receptor gamma-coactivator-1 alpha coordinates sphingolipid metabolism, lipid raft composition and myelin protein synthesis

European Journal of Neuroscience

Volumn 38, Issue 5, 2013, Pages 2672-2683

  Camacho, Alberto ^a,f   Huang, Jeffrey K ^b   Delint Ramirez, Ilse ^c   Yew Tan, Chong ^a   Fuller, Maria ^d   Lelliott, Christopher J ^e   Vidal Puig, Antonio ^a   Franklin, Robin J M ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b University of Cambridge   (United Kingdom)

^c UNIVERSIDAD AUTÓNOMA DE NUEVO LEÓN   (Mexico)

^d SA Pathology ^*  (Australia)

^e ASTRAZENECA R AND D   (Sweden)

^f Center for Research and Development in Health Sciences   (Mexico)

Author keywords

Lipid rafts; Lipidomics; Mouse; Myelin; Oligodendrocyte; Peroxisome proliferator activated receptor gamma coactivator 1 alpha

Indexed keywords

CERAMIDE; GANGLIOSIDE GM1; GANGLIOSIDE GM2; GLUCOCYLCERAMIDE; LACTOSYLCERAMIDE; MYELIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLINOSITOL; SPHINGOLIPID; TRANSCRIPTION FACTOR NKX2.2; TRANSCRIPTION FACTOR SOX10; TRANSCRIPTION FACTOR SOX9; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CEREBELLUM; CONTROLLED STUDY; LIPID ANALYSIS; LIPID COMPOSITION; LIPID METABOLISM; LIPID RAFT; LIPIDOMICS; MALE; MOUSE; MUTANT; MYELINATION; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SYNTHESIS; TRANSCRIPTION REGULATION; WILD TYPE;

EID: 84883462211     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/ejn.12281     Document Type: Article

References (72)

1. Adibhatla, R.M. & Hatcher, J.F. (2010) Lipid oxidation and peroxidation in CNS health and disease: from molecular mechanisms to therapeutic opportunities. Antioxid. Redox Sign., 12, 125-169.
2. Aliche-Djoudi, F., Podechard, N., Chevanne, M., Nourissat, P., Catheline, D., Legrand, P., Dimanche-Boitrel, M.T., Lagadic-Gossmann, D. & Sergent, O. (2011) Physical and chemical modulation of lipid rafts by a dietary n-3 polyunsaturated fatty acid increases ethanol-induced oxidative stress. Free Radical Bio. Med., 51, 2018-2030.
3. Baes, M. & Aubourg, P. (2009) Peroxisomes, myelination, and axonal integrity in the CNS. Neuroscientist, 15, 367-379.
4. Baron, W. & Hoekstra, D. (2010) On the biogenesis of myelin membranes: sorting, trafficking and cell polarity. FEBS Lett., 584, 1760-1770.
5. Baron, W., Decker, L., Colognato, H. & ffrench-Constant, C. (2003) Regulation of integrin growth factor interactions in oligodendrocytes by lipid raft microdomains. Curr. Biol., 13, 151-155.
6. Bligh, E.G. & Dyer, W.J. (1959) A rapid method of total lipid extraction and purification. Can. J. Biochem. Phys., 37, 911-917.
7. Bottelbergs, A., Verheijden, S., Van Veldhoven, P.P., Just, W., Devos, R. & Baes, M. (2012) Peroxisome deficiency but not the defect in ether lipid synthesis causes activation of the innate immune system and axonal loss in the central nervous system. J. Neuroinflamm., 9, 61.
8. Bradl, M. & Lassmann, H. (2010) Oligodendrocytes: biology and pathology. Acta Neuropathol., 119, 37-53.
9. Bremer, J., Baumann, F., Tiberi, C., Wessig, C., Fischer, H., Schwarz, P., Steele, A.D., Toyka, K.V., Nave, K.A., Weis, J. & Aguzzi, A. (2010) Axonal prion protein is required for peripheral myelin maintenance. Nat. Neurosci., 13, 310-318.
10. Camacho, A., Montiel, T. & Massieu, L. (2007) Sustained metabolic inhibition induces an increase in the content and phosphorylation of the NR2B subunit of N-methyl-D-aspartate receptors and a decrease in glutamate transport in the rat hippocampus in vivo. Neuroscience, 145, 873-886.
11. Castro, B.M., Silva, L.C., Fedorov, A., de Almeida, R.F. & Prieto, M. (2009) Cholesterol-rich fluid membranes solubilize ceramide domains: implications for the structure and dynamics of mammalian intracellular and plasma membranes. J. Biol. Chem., 284, 22978-22987.
12. Contreras, F.X., Villar, A.V., Alonso, A., Kolesnick, R.N. & Goni, F.M. (2003) Sphingomyelinase activity causes transbilayer lipid translocation in model and cell membranes. J. Biol. Chem., 278, 37169-37174.
13. Cui, L., Jeong, H., Borovecki, F., Parkhurst, C.N., Tanese, N. & Krainc, D. (2006) Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cell, 127, 59-69.
14. Dawson, G., Fuller, M., Helmsley, K.M. & Hopwood, J.J. (2012) Abnormal gangliosides are localized in lipid rafts in Sanfilippo (MPS3a) mouse brain. Neurochem. Res., 37, 1372-1380.
15. De Nuccio, C., Bernardo, A., De Simone, R., Mancuso, E., Magnaghi, V., Visentin, S. & Minghetti, L. (2011) Peroxisome proliferator-activated receptor gamma agonists accelerate oligodendrocyte maturation and influence mitochondrial functions and oscillatory Ca(2+) waves. J. Neuropath. Exp. Neur., 70, 900-912.
16. De Robertis, E., Gerschenfeld, H.M. & Wald, F. (1958) Cellular mechanism of myelination in the central nervous system. J. Biophys. Biochem. Cy., 4, 651-656.
17. Decker, L., Baron, W. & Ffrench-Constant, C. (2004) Lipid rafts: microenvironments for integrin-growth factor interactions in neural development. Biochem. Soc. T., 32, 426-430.
18. Denny, C.A., Kasperzyk, J.L., Gorham, K.N., Bronson, R.T. & Seyfried, T.N. (2006) Influence of caloric restriction on motor behavior, longevity, and brain lipid composition in Sandhoff disease mice. J. Neurosci. Res., 83, 1028-1038.
19. D'Errico, I., Salvatore, L., Murzilli, S., Lo Sasso, G., Latorre, D., Martelli, N., Egorova, A.V., Polishuck, R., Madeyski-Bengtson, K., Lelliott, C., Vidal-Puig, A.J., Seibel, P., Villani, G. & Moschetta, A. (2011) Peroxisome proliferator-activated receptor-gamma coactivator 1-alpha (PGC1alpha) is a metabolic regulator of intestinal epithelial cell fate. Proc. Natl. Acad. Sci. USA, 108, 6603-6608.
20. Dyer, C.A. & Benjamins, J.A. (1988) Antibody to galactocerebroside alters organization of oligodendroglial membrane sheets in culture. J. Neurosci., 8, 4307-4318.
21. Espinoza, D.O., Boros, L.G., Crunkhorn, S., Gami, H. & Patti, M.E. (2010) Dual modulation of both lipid oxidation and synthesis by peroxisome proliferator-activated receptor-gamma coactivator-1alpha and -1beta in cultured myotubes. FASEB J., 24, 1003-1014.
22. Fancy, S.P., Baranzini, S.E., Zhao, C., Yuk, D.I., Irvine, K.A., Kaing, S., Sanai, N., Franklin, R.J. & Rowitch, D.H. (2009) Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS. Gene. Dev., 23, 1571-1585.
23. Fancy, S.P., Chan, J.R., Baranzini, S.E., Franklin, R.J. & Rowitch, D.H. (2011) Myelin regeneration: a recapitulation of development? Annu. Rev. Neurosci., 34, 21-43.
24. Folch, J., Lees, M. & Sloane Stanley, G.H. (1957) A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem., 226, 497-509.
25. Guan, Z. (2009) Discovering novel brain lipids by liquid chromatography/tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 877, 2814-2821.
26. Han, X., Cheng, H., Fryer, J.D., Fagan, A.M. & Holtzman, D.M. (2003) Novel role for apolipoprotein E in the central nervous system. Modulation of sulfatide content. J. Biol. Chem., 278, 8043-8051.
27. Hein, L.K., Duplock, S., Hopwood, J.J. & Fuller, M. (2008) Lipid composition of microdomains is altered in a cell model of Gaucher disease. J. Lipid Res., 49, 1725-1734.
28. Jackman, N., Ishii, A. & Bansal, R. (2009) Oligodendrocyte development and myelin biogenesis: parsing out the roles of glycosphingolipids. Physiology (Bethesda), 24, 290-297.
29. Jurevics, H., Hostettler, J., Muse, E.D., Sammond, D.W., Matsushima, G.K., Toews, A.D. & Morell, P. (2001) Cerebroside synthesis as a measure of the rate of remyelination following cuprizone-induced demyelination in brain. J. Neurochem., 77, 1067-1076.
30. -/- mouse cortex: a potential lipidomic role of PGC-1alpha in neurodegeneration. J. Lipid Res., 53, 273-281.
31. Klugmann, M., Schwab, M.H., Puhlhofer, A., Schneider, A., Zimmermann, F., Griffiths, I.R. & Nave, K.A. (1997) Assembly of CNS myelin in the absence of proteolipid protein. Neuron, 18, 59-70.
32. Langelier, B., Linard, A., Bordat, C., Lavialle, M. & Heberden, C. (2010) Long chain-polyunsaturated fatty acids modulate membrane phospholipid composition and protein localization in lipid rafts of neural stem cell cultures. J. Cell. Biochem., 110, 1356-1364.
33. Leisewitz, A.V., Urrutia, C.R., Martinez, G.R., Loyola, G. & Bronfman, M. (2008) A PPARs cross-talk concertedly commits C6 glioma cells to oligodendrocytes and induces enzymes involved in myelin synthesis. J. Cell. Physiol., 217, 367-376.
34. Leone, T.C., Lehman, J.J., Finck, B.N., Schaeffer, P.J., Wende, A.R., Boudina, S., Courtois, M., Wozniak, D.F., Sambandam, N., Bernal-Mizrachi, C., Chen, Z., Holloszy, J.O., Medeiros, D.M., Schmidt, R.E., Saffitz, J.E., Abel, E.D., Semenkovich, C.F. & Kelly, D.P. (2005) PGC-1alpha deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis. PLoS Biol., 3, e101.
35. Leskova, G.F. & Kryzhanovsky, G.N. (2011) Changes in phospholipid composition of cardiomyocyte plasma membranes during hemorrhagic shock. Bull. Exp. Biol. Med., 151, 284-287.
36. Liebisch, G., Binder, M., Schifferer, R., Langmann, T., Schulz, B. & Schmitz, G. (2006) High throughput quantification of cholesterol and cholesteryl ester by electrospray ionization tandem mass spectrometry (ESI-MS/MS). Biochim. Biophys. Acta, 1761, 121-128.
37. Lin, J., Wu, H., Tarr, P.T., Zhang, C.Y., Wu, Z., Boss, O., Michael, L.F., Puigserver, P., Isotani, E., Olson, E.N., Lowell, B.B., Bassel-Duby, R. & Spiegelman, B.M. (2002) Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature, 418, 797-801.
38. Lin, J., Wu, P.H., Tarr, P.T., Lindenberg, K.S., St-Pierre, J., Zhang, C.Y., Mootha, V.K., Jager, S., Vianna, C.R., Reznick, R.M., Cui, L., Manieri, M., Donovan, M.X., Wu, Z., Cooper, M.P., Fan, M.C., Rohas, L.M., Zavacki, A.M., Cinti, S., Shulman, G.I., Lowell, B.B., Krainc, D. & Spiegelman, B.M. (2004) Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice. Cell, 119, 121-135.
39. Lisanti, M.P., Sargiacomo, M., Graeve, L., Saltiel, A.R. & Rodriguez-Boulan, E. (1988) Polarized apical distribution of glycosyl-phosphatidylinositol-anchored proteins in a renal epithelial cell line. Proc. Natl. Acad. Sci. USA, 85, 9557-9561.
40. Liu, C. & Lin, J.D. (2011) PGC-1 coactivators in the control of energy metabolism. Acta Biochim. Biophys. Sin. (Shanghai), 43, 248-257.
41. Lowry, O.H., Rosebrough, N.J., Farr, A.L. & Randall, R.J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193, 265-275.
42. Ludwin, S.K. (1997) The pathobiology of the oligodendrocyte. J. Neuropath. Exp. Neur., 56, 111-124.
43. Maier, O., Hoekstra, D. & Baron, W. (2008) Polarity development in oligodendrocytes: sorting and trafficking of myelin components. J. Mol. Neurosci., 35, 35-53.
44. Marcus, J. & Popko, B. (2002) Galactolipids are molecular determinants of myelin development and axo-glial organization. Biochim. Biophys. Acta, 1573, 406-413.
45. McLaurin, J.A. & Yong, V.W. (1995) Oligodendrocytes and myelin. Neurol. Clin., 13, 23-49.
46. McTigue, D.M. & Tripathi, R.B. (2008) The life, death, and replacement of oligodendrocytes in the adult CNS. J. Neurochem., 107, 1-19.
47. Medina-Gomez, G., Virtue, S., Lelliott, C., Boiani, R., Campbell, M., Christodoulides, C., Perrin, C., Jimenez-Linan, M., Blount, M., Dixon, J., Zahn, D., Thresher, R.R., Aparicio, S., Carlton, M., Colledge, W.H., Kettunen, M.I., Seppanen-Laakso, T., Sethi, J.K., O'Rahilly, S., Brindle, K., Cinti, S., Oresic, M., Burcelin, R. & Vidal-Puig, A. (2005) The link between nutritional status and insulin sensitivity is dependent on the adipocyte-specific peroxisome proliferator-activated receptor-gamma2 isoform. Diabetes, 54, 1706-1716.
48. Megha & London, E. (2004) Ceramide selectively displaces cholesterol from ordered lipid domains (rafts): implications for lipid raft structure and function. J. Biol. Chem., 279, 9997-10004.
49. Meikle, P.J., Duplock, S., Blacklock, D., Whitfield, P.D., Macintosh, G., Hopwood, J.J. & Fuller, M. (2008) Effect of lysosomal storage on bis(monoacylglycero)phosphate. Biochem. J., 411, 71-78.
50. Norton, W.T. & Autilio, L.A. (1966) The lipid composition of purified bovine brain myelin. J. Neurochem., 13, 213-222.
51. O'Brien, J.S. & Sampson, E.L. (1965) Lipid composition of the normal human brain: gray matter, white matter, and myelin. J. Lipid Res., 6, 537-544.
52. Pellerin, L. (2008) Brain energetics (thought needs food). Curr. Opin. Clin. Nutr. Metab. Care, 11, 701-705.
53. Puigserver, P., Wu, Z., Park, C.W., Graves, R., Wright, M. & Spiegelman, B.M. (1998) A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell, 92, 829-839.
54. Qi, Y., Cai, J., Wu, Y., Wu, R., Lee, J., Fu, H., Rao, M., Sussel, L., Rubenstein, J. & Qiu, M. (2001) Control of oligodendrocyte differentiation by the Nkx2.2 homeodomain transcription factor. Development, 128, 2723-2733.
55. Roth, A.D., Leisewitz, A.V., Jung, J.E., Cassina, P., Barbeito, L., Inestrosa, N.C. & Bronfman, M. (2003) PPAR gamma activators induce growth arrest and process extension in B12 oligodendrocyte-like cells and terminal differentiation of cultured oligodendrocytes. J. Neurosci. Res., 72, 425-435.
56. Ruiz-Arguello, M.B., Veiga, M.P., Arrondo, J.L., Goni, F.M. & Alonso, A. (2002) Sphingomyelinase cleavage of sphingomyelin in pure and mixed lipid membranes. Influence of the physical state of the sphingolipid. Chem. Phys. Lipids, 114, 11-20.
57. Saher, G., Brugger, B., Lappe-Siefke, C., Mobius, W., Tozawa, R., Wehr, M.C., Wieland, F., Ishibashi, S. & Nave, K.A. (2005) High cholesterol level is essential for myelin membrane growth. Nat. Neurosci., 8, 468-475.
58. Saluja, I., Granneman, J.G. & Skoff, R.P. (2001) PPAR delta agonists stimulate oligodendrocyte differentiation in tissue culture. Glia, 33, 191-204.
59. Scandroglio, F., Venkata, J.K., Loberto, N., Prioni, S., Schuchman, E.H., Chigorno, V., Prinetti, A. & Sonnino, S. (2008) Lipid content of brain, brain membrane lipid domains, and neurons from acid sphingomyelinase deficient mice. J. Neurochem., 107, 329-338.
60. Scarpulla, R.C. (2008) Transcriptional paradigms in mammalian mitochondrial biogenesis and function. Physiol. Rev., 88, 611-638.
61. Seyfried, T.N. & Yu, R.K. (1980) Heterosis for brain myelin content in mice. Biochem. Genet., 18, 1229-1237.
62. Shine, H.D., Readhead, C., Popko, B., Hood, L. & Sidman, R.L. (1992) Morphometric analysis of normal, mutant, and transgenic CNS: correlation of myelin basic protein expression to myelinogenesis. J. Neurochem., 58, 342-349.
63. St-Pierre, J., Drori, S., Uldry, M., Silvaggi, J.M., Rhee, J., Jager, S., Handschin, C., Zheng, K., Lin, J., Yang, W., Simon, D.K., Bachoo, R. & Spiegelman, B.M. (2006) Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell, 127, 397-408.
64. Summermatter, S., Baum, O., Santos, G., Hoppeler, H. & Handschin, C. (2010) Peroxisome proliferator-activated receptor gamma coactivator 1{alpha} (PGC-1{alpha}) promotes skeletal muscle lipid refueling in vivo by activating de novo lipogenesis and the pentose phosphate pathway. J. Biol. Chem., 285, 32793-32800.
65. Verheijen, M.H., Camargo, N., Verdier, V., Nadra, K., de Preux Charles, A.S., Medard, J.J., Luoma, A., Crowther, M., Inouye, H., Shimano, H., Chen, S., Brouwers, J.F., Helms, J.B., Feltri, M.L., Wrabetz, L., Kirschner, D., Chrast, R. & Smit, A.B. (2009) SCAP is required for timely and proper myelin membrane synthesis. Proc. Natl. Acad. Sci. USA, 106, 21383-21388.
66. Viader, A., Golden, J.P., Baloh, R.H., Schmidt, R.E., Hunter, D.A. & Milbrandt, J. (2011) Schwann cell mitochondrial metabolism supports long-term axonal survival and peripheral nerve function. J. Neurosci., 31, 10128-10140.
67. de Vries, H. & Hoekstra, D. (2000) On the biogenesis of the myelin sheath: cognate polarized trafficking pathways in oligodendrocytes. Glycoconjugate J., 17, 181-190.
68. Watanabe, M., Hadzic, T. & Nishiyama, A. (2004) Transient upregulation of Nkx2.2 expression in oligodendrocyte lineage cells during remyelination. Glia, 46, 311-322.
69. Wheeler, D., Bandaru, V.V., Calabresi, P.A., Nath, A. & Haughey, N.J. (2008) A defect of sphingolipid metabolism modifies the properties of normal appearing white matter in multiple sclerosis. Brain, 131, 3092-3102.
70. Xiang, Z., Valenza, M., Cui, L., Leoni, V., Jeong, H.K., Brilli, E., Zhang, J., Peng, Q., Duan, W., Reeves, S.A., Cattaneo, E. & Krainc, D. (2011) Peroxisome-proliferator-activated receptor gamma coactivator 1 alpha contributes to dysmyelination in experimental models of Huntington's disease. J. Neurosci., 31, 9544-9553.
71. Yaqoob, P. & Shaikh, S.R. (2010) The nutritional and clinical significance of lipid rafts. Curr. Opin. Clin. Nutr. Metab. Care, 13, 156-166.
72. Zeger, M., Popken, G., Zhang, J., Xuan, S., Lu, Q.R., Schwab, M.H., Nave, K.A., Rowitch, D., D'Ercole, A.J. & Ye, P. (2007) Insulin-like growth factor type 1 receptor signaling in the cells of oligodendrocyte lineage is required for normal in vivo oligodendrocyte development and myelination. Glia, 55, 400-411.